相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow Cytometry
Hideki Hosono et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021)
Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin
Tomohiro Tanaka et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021)
Role of Rho GTPases in stem cell regulation
Zheng Zhang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
The biology and rationale of targeting nectin-4 in urothelial carcinoma
Elisabeth I. Heath et al.
NATURE REVIEWS UROLOGY (2021)
Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy
F. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma
Jun Suzuki et al.
LUNG CANCER (2021)
The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology
Jillian L. Astarita et al.
PLOS ONE (2021)
Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs
Stanislav Pantelyushin et al.
CANCERS (2021)
PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
Naoya Maekawa et al.
NPJ PRECISION ONCOLOGY (2021)
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
Masatoshi Kanayama et al.
ONCOLOGY LETTERS (2021)
Mechanisms of Therapeutic Antitumor Monoclonal Antibodies
Li-Chung Tsao et al.
CANCER RESEARCH (2021)
The Role of CLEC-2 and Its Ligands in Thromboinflammation
Danyang Meng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression
Alessandra Pecora et al.
CANCERS (2021)
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif et al.
CANCERS (2021)
Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues
Attila Braun et al.
FRONTIERS IN ONCOLOGY (2021)
Podoplanin drives dedifferentiation and amoeboid invasion of melanoma
Charlotte M. de Winde et al.
ISCIENCE (2021)
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity
Hisataka Kobayashi et al.
INTERNATIONAL IMMUNOLOGY (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert et al.
NATURE REVIEWS CANCER (2021)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Fibroblasts-dependent invasion of podoplanin-positive cancer stem cells in squamous cell carcinoma
Tomoyuki Miyashita et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the Universal CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2
Taiji Kuwata et al.
CELLS (2020)
Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin
Yuko Nishinaga et al.
CELLS (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
Kohei Shitara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides
Preeti Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Podoplanin as an Attractive Target of CAR T Cell Therapy
Masazumi Waseda et al.
CELLS (2020)
Tumor Cellular and Microenvironmental Cues Controlling Invadopodia Formation
Ilenia Masi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
Therapeutic efficacy evaluation of radioimmunotherapy with 90Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma
Hitomi Sudo et al.
CANCER SCIENCE (2019)
Podoplanin in Inflammation and Cancer
Miguel Quintanilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer
Pawel Bieniasz-Krzywiec et al.
CELL METABOLISM (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Development of Targeted Alpha Particle Therapy for Solid Tumors
Narges K. Tafreshi et al.
MOLECULES (2019)
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma
Kazue Yoneda et al.
CANCER SCIENCE (2019)
Application of the NZ-1 Fab as a crystallization chaperone for PA tag-inserted target proteins
Risako Tamura et al.
PROTEIN SCIENCE (2019)
Multiple cancer-specific antigens are targeted by a chimeric antibody receptor on a single cancer cell
Yanran He et al.
JCI INSIGHT (2019)
PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin
Yoshikazu Furusawa et al.
HELIYON (2019)
Mechanoreciprocity in cell migration
Sjoerd van Helvert et al.
NATURE CELL BIOLOGY (2018)
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front
Akiko Kunita et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Podoplanin: An emerging cancer biomarker and therapeutic target
Harini Krishnan et al.
CANCER SCIENCE (2018)
Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin
Yao-yin Li et al.
EXPERIMENTAL CELL RESEARCH (2018)
Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma
Kousuke Sasaki et al.
HUMAN PATHOLOGY (2018)
Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions
Hiroshi Nakamura et al.
LUNG CANCER (2018)
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer
Akihiro Miyazaki et al.
Oncotarget (2018)
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
David M. Goldenberg et al.
Oncotarget (2018)
Immunotherapy for Dogs: Running Behind Humans
Hans Klingemann
FRONTIERS IN IMMUNOLOGY (2018)
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
Norio Chihara et al.
NATURE (2018)
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
Takao Ukaji et al.
Oncotarget (2018)
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma
Takashi Sakai et al.
LUNG CANCER (2018)
Cell motility in cancer invasion and metastasis: insights from simple model organisms
Christina H. Stuelten et al.
NATURE REVIEWS CANCER (2018)
Modes of invasion during tumour dissemination
Pahini Pandya et al.
MOLECULAR ONCOLOGY (2017)
Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity
Mika K. Kaneko et al.
CANCER MEDICINE (2017)
Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells
Tomoyuki Miyashita et al.
SCIENTIFIC REPORTS (2017)
Platelet-activating factor podoplanin: from discovery to drug development
Ai Takemoto et al.
CANCER AND METASTASIS REVIEWS (2017)
Targeted Radionuclide Therapy of Human Tumors
Sergey V. Gudkov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
Takaya Sekiguchi et al.
ONCOTARGET (2016)
Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis
Katsutoshi Ando et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Plasticity of Cell Migration In Vivo and In Silico
Veronika te Boekhorst et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 32 (2016)
Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
Yu Xia et al.
CANCER SCIENCE (2016)
CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains
Satoshi Shiina et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Immunoregulation by members of the TGFβ superfamily
WanJun Chen et al.
NATURE REVIEWS IMMUNOLOGY (2016)
PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility
Harini Krishnan et al.
EXPERIMENTAL CELL RESEARCH (2015)
Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma
Makiko Tanaka et al.
MOLECULAR MEDICINE REPORTS (2015)
Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C
Hyun-Yi Kim et al.
ONCOLOGY REPORTS (2015)
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity
Yukinari Kato et al.
ONCOTARGET (2015)
Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation
Tatsuya Yoshida et al.
CLINICAL CANCER RESEARCH (2015)
Podoplanin negatively regulates CD4(+) effector T cell responses
Anneli Peters et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability
E. Martin-Villar et al.
ONCOGENE (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
Clinical significance of macrophage heterogeneity in human malignant tumors
Yoshihiro Komohara et al.
CANCER SCIENCE (2014)
Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis
Satoshi Takagi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life
Paul R. Hess et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ebp1 activates podoplanin expression and contributes to oral tumorigenesis
Y. Mei et al.
ONCOGENE (2014)
PA tag: A versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin
Yuki Fujii et al.
PROTEIN EXPRESSION AND PURIFICATION (2014)
A Platform of C-type Lectin-like Receptor CLEC-2 for Binding O-Glycosylated Podoplanin and Nonglycosylated Rhodocytin
Masamichi Nagae et al.
STRUCTURE (2014)
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
Yukinari Kato et al.
SCIENTIFIC REPORTS (2014)
Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion
Yuichiro Nakashima et al.
CANCER SCIENCE (2013)
Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus
Sebastian F. Schoppmann et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
Vidyalakshmi Chandramohan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
G. Daniel Grass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody
Shinji Abe et al.
JOURNAL OF IMMUNOLOGY (2013)
Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas
Koji Shindo et al.
MOLECULAR CANCER (2013)
Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions
Melda Tozluoglu et al.
NATURE CELL BIOLOGY (2013)
Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines
Mitsuhiko Ohta et al.
ORAL ONCOLOGY (2013)
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
Satoshi Takagi et al.
PLOS ONE (2013)
Immunohistochemical Examination of Novel Rat Monoclonal Antibodies against Mouse and Human Podoplanin
Chiaki Kaji et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2012)
Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma
Shinya Neri et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity
Suguru Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity
Mika Kato Kaneko et al.
CANCER SCIENCE (2012)
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas
Kazuya Motomura et al.
CANCER SCIENCE (2012)
Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression
Young Sun Hwang et al.
CARCINOGENESIS (2012)
Prognostic Impact of Cancer-Associated Stromal Cells in Patients With Stage I Lung Adenocarcinoma
Masami Ito et al.
CHEST (2012)
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis
Naoya Fujita et al.
JOURNAL OF BIOCHEMISTRY (2012)
Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation
Heike Peterziel et al.
NEURO-ONCOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Podoplanin Is Regulated by AP-1 and Promotes Platelet Aggregation and Cell Migration in Osteosarcoma
Akiko Kunita et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression
Ayuko Hoshino et al.
CANCER RESEARCH (2011)
Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies
Youya Nakazawa et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma
Bartosz Pula et al.
HISTOPATHOLOGY (2011)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy
Matthias Kreppel et al.
ORAL ONCOLOGY (2011)
High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma
Hanako Suzuki et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma
Nur Rahadiani et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation
Pavel Uhrin et al.
BLOOD (2010)
Src Induces Podoplanin Expression to Promote Cell Migration
Yongquan Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Podoplanin Associates with CD44 to Promote Directional Cell Migration
Ester Martin-Villar et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas
Yukinari Kato et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors
Takashi Ariizumi et al.
PATHOLOGY INTERNATIONAL (2010)
Antibody recognition of a unique tumor-specific glycopeptide antigen
Cory L. Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations
Matthias Kreppel et al.
VIRCHOWS ARCHIV (2010)
D2-40 Immunohistochemistry - So Far!
Alexandra N. Kalof et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
Yoshihisa Shimada et al.
CANCER SCIENCE (2009)
Embryonic Stem Cell Transcription Factors and D2-40 (Podoplanin) as Diagnostic Immunohistochemical Markers in Ovarian Germ Cell Tumors
Martin C. Chang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2009)
Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI
Y. Ozaki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
Matthias Miederer et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model
Klaas Koop et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431
Naho Atsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Podoplanin is a novel Fos target gene in skin carcinogenesis
Moritz Durchdewald et al.
CANCER RESEARCH (2008)
Characterization of anti-podoplanin monoclonal antibodies: Critical epitopes for neutralizing the interaction between podoplanin and CLEC-2
Satoshi Ogasawara et al.
HYBRIDOMA (2008)
Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
C. E. Hughes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Fromter rats
D. H. T. IJpelaar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma
Hiroyuki Suzuki et al.
FEBS LETTERS (2008)
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Molecular regulation of angiogenesis and lymphangiogenesis
Ralf H. Adams et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade
Gemma L. J. Fuller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells
Brigitte Hantusch et al.
BMC MOLECULAR BIOLOGY (2007)
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2
Aleksandra A. Watson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional glycosylation of human podoplanin: Glycan structure of platelet aggregation-inducing factor
Mika Kato Kaneko et al.
FEBS LETTERS (2007)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
Ester Martin-Villar et al.
JOURNAL OF CELL SCIENCE (2006)
A mutant chaperone converts a wild-type protein into a tumor-specific antigen
Andrea Schietinger et al.
SCIENCE (2006)
Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor
Mika Kato Kaneko et al.
GENE (2006)
ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo
Jeffrey B. Wyckoff et al.
CURRENT BIOLOGY (2006)
Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma
Kazuhiko Mishima et al.
ACTA NEUROPATHOLOGICA (2006)
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
K Mishima et al.
ACTA NEUROPATHOLOGICA (2006)
Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton
A Wicki et al.
CANCER CELL (2006)
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
K Suzuki-Inoue et al.
BLOOD (2006)
Crystallization and X-ray diffraction analysis of human CLEC-2
AA Watson et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
V Schacht et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Functional sialylated O-glycan to platelet aggregation on Aggrus (T1α/podoplanin) molecules expressed in Chinese hamster ovary cells
M Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors
Y Kato et al.
ONCOGENE (2004)
Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors
Y Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
V Schacht et al.
EMBO JOURNAL (2003)
Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells
S Hirakawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor
TV Petrova et al.
EMBO JOURNAL (2002)
Molecular mechanisms of lymphangiogenesis in health and disease
K Alitalo et al.
CANCER CELL (2002)
分享论文
